Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a consent form agreeing to take part in the study before any study-related procedures begin
- People who have been diagnosed with colorectal cancer confirmed through a tissue sample (biopsy)
- People whose treatment plan includes one or more of the following chemotherapy drugs: Capecitabine, Oxaliplatin, 5-Fluorouracil, or Irinotecan
- People who have not yet received any chemotherapy treatment before joining the study
Who may not be able to join:
- People who have previously received any chemotherapy, radiation therapy, immunotherapy, or experimental cancer treatments
- People whose ability to complete surveys is assessed by the lead study doctor as being significantly limited due to mental capacity
- People who are currently pregnant or breastfeeding
- People who have cancer that has spread to the brain
- People who do not speak English
- People who have been diagnosed with a brain or cognitive condition, including traumatic brain injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, or Creutzfeldt-Jakob disease
- People whom the lead study doctor or coordinator considers unsuitable for participation for any other reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joseph McCollom, DO, Parkview Health
Phone: 260-266-7100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Survey; The Proteome Profiler Human XL Cytokine Array Kit (https://www.rndsystems.com/products/proteome-profiler-human-xl-cytokine-array-kit_ary022b)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.